메뉴 건너뛰기




Volumn 30, Issue 10, 2011, Pages 1369-1372

The efficacy and safety of etanercept in patients with rheumatoid arthritis and spondyloarthropathy on hemodialysis

Author keywords

Ankylosing spondylitis; Anti TNF; Etanercept; Hemodialysis; Rheumatoid arthritis; Spondyloarthropathy

Indexed keywords

C REACTIVE PROTEIN; CORTICOSTEROID; ETANERCEPT; HYDROXYCHLOROQUINE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ANTIBODY;

EID: 80955180088     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-011-1782-6     Document Type: Article
Times cited : (22)

References (12)
  • 2
    • 0031972623 scopus 로고    scopus 로고
    • Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors
    • DOI 10.1002/1529-0131(199801)41:1<58::AID-ART8>3.0.CO;2-G
    • J Braun M Bollow G Remlinger, et al. 1998 Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors Arthritis Rheum 41 58 67 9433870 10.1002/1529-0131(199801)41:1<58::AID-ART8>3.0. CO;2-G 1:STN:280:DyaK1c%2Fptl2muw%3D%3D (Pubitemid 28041923)
    • (1998) Arthritis and Rheumatism , vol.41 , Issue.1 , pp. 58-67
    • Braun, J.1    Bollow, M.2    Remlinger, G.3    Eggens, U.4    Rudwaleit, M.5    Distler, A.6    Sieper, J.7
  • 4
    • 4043090493 scopus 로고    scopus 로고
    • Dosing of antirheumatic drugs in renal disease and dialysis
    • DOI 10.1097/01.rhu.0000135555.83088.a2
    • A Swarup N Sachdeva HR Schumacher Jr 2004 Dosing of antirheumatic drugs in renal disease and dialysis J Clin Rheumatol 10 190 204 17043508 10.1097/01.rhu.0000135555.83088.a2 (Pubitemid 39079595)
    • (2004) Journal of Clinical Rheumatology , vol.10 , Issue.4 , pp. 190-204
    • Swarup, A.1    Sachdeva, N.2    Schumacher Jr., H.R.3
  • 5
    • 33750046010 scopus 로고    scopus 로고
    • Methotrexate should not be used for patients with end-stage kidney disease
    • O Boey S Van Hooland A Woestenburg P Van der Niepen D Verbeelen 2006 Methotrexate should not be used for patients with end-stage kidney disease Acta Clin Belg 61 166 169 17091912 1:STN:280:DC%2BD28nlvVegtw%3D%3D (Pubitemid 44577266)
    • (2006) Acta Clinica Belgica , vol.61 , Issue.4 , pp. 166-169
    • Boey, O.1    Van Hooland, S.2    Woestenburg, A.3    Van Der Niepen, P.4    Verbeelen, D.5
  • 6
    • 33644865452 scopus 로고    scopus 로고
    • Infliximab treatment in a patient with rheumatoid arthritis on haemodialysis [6]
    • DOI 10.1093/rheumatology/kei264
    • M Hammoudeh 2006 Infliximab treatment in a patient with rheumatoid arthritis on haemodialysis Rheumatology 45 357 359 16368727 10.1093/ rheumatology/kei264 1:STN:280:DC%2BD287gt1Smug%3D%3D (Pubitemid 43372859)
    • (2006) Rheumatology , vol.45 , Issue.3 , pp. 357-359
    • Hammoudeh, M.1
  • 7
    • 84863862501 scopus 로고    scopus 로고
    • Efficacy and safety of adalimumab in a patient with ankylosing spondylitis on peritoneal dialysis
    • 10.1007/s00296-010-1457-7
    • S Kobak 2010 Efficacy and safety of adalimumab in a patient with ankylosing spondylitis on peritoneal dialysis Rheumatol Int 10.1007/s00296-010- 1457-7
    • (2010) Rheumatol Int
    • Kobak, S.1
  • 8
    • 77957006741 scopus 로고    scopus 로고
    • Infliximab in a patient with ankylosing spondylitis and secondary IgA nephropathy requiring haemodialysis
    • 20576230
    • E Marocchi A Spadaro K Giannakakis R Priori G Valesini 2010 Infliximab in a patient with ankylosing spondylitis and secondary IgA nephropathy requiring haemodialysis Clin Exp Rheumatol 28 440 20576230
    • (2010) Clin Exp Rheumatol , vol.28 , pp. 440
    • Marocchi, E.1    Spadaro, A.2    Giannakakis, K.3    Priori, R.4    Valesini, G.5
  • 9
    • 34548084289 scopus 로고    scopus 로고
    • The pharmacokinetics of etanercept in patients with end-stage renal disease on haemodialysis
    • DOI 10.1211/jpp.57.11.0005
    • BR Don G Spin I Nestorov M Hutmacher A Rose GA Kaysen 2005 The pharmacokinetics of etanercept in patients with end-stage renal disease on haemodialysis J Pharm Pharmacol 57 1407 1413 16259772 10.1211/jpp.57.11.0005 1:CAS:528:DC%2BD2MXht1Ons7rL (Pubitemid 350066982)
    • (2005) Journal of Pharmacy and Pharmacology , vol.57 , Issue.11 , pp. 1407-1413
    • Don, B.R.1    Spin, G.2    Nestorov, I.3    Hutmacher, M.4    Rose, A.5    Kaysen, G.A.6
  • 10
    • 77952618631 scopus 로고    scopus 로고
    • The effect of etanercept on suppression of the systemic inflammatory response in chronic hemodialysis patients
    • 20497755 1:CAS:528:DC%2BC3cXpsFOitb0%3D
    • BR Don K Kim J Li T Dwyer F Alexander GA Kaysen 2010 The effect of etanercept on suppression of the systemic inflammatory response in chronic hemodialysis patients Clin Nephrol 73 431 438 20497755 1:CAS:528: DC%2BC3cXpsFOitb0%3D
    • (2010) Clin Nephrol , vol.73 , pp. 431-438
    • Don, B.R.1    Kim, K.2    Li, J.3    Dwyer, T.4    Alexander, F.5    Kaysen, G.A.6
  • 12
    • 50149093269 scopus 로고    scopus 로고
    • Etanercept treatment in a hemodialysis patient with severe cyclosporine-resistant psoriasis and hepatitis C virus infection
    • 18937672 10.1111/j.1365-4632.2008.03619.x
    • N Cassano GA Vena 2008 Etanercept treatment in a hemodialysis patient with severe cyclosporine-resistant psoriasis and hepatitis C virus infection Int J Dermatol 47 980 981 18937672 10.1111/j.1365-4632.2008.03619.x
    • (2008) Int J Dermatol , vol.47 , pp. 980-981
    • Cassano, N.1    Vena, G.A.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.